Applications of bacterial ghosts in biomedicine

Advances in Experimental Medicine and Biology

Volumn 655, Issue , 2009, Pages 159-170

  Lubitz, Petra ^b   Mayr, Ulrike Beate ^b   Lubitz, Werner ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; DNA; DNA VACCINE; DOXORUBICIN; DRUG CARRIER; DRUG VEHICLE; ESCHERICHIA COLI VACCINE; PROBIOTIC AGENT; SUBUNIT VACCINE; BACTERIAL VACCINE;

ARTICLE; BACTERIAL GHOST; BACTERIAL MEMBRANE; BIOMEDICINE; CANCER THERAPY; DNA IMMUNIZATION; DNA TRANSFER; DRUG TARGETING; ENZYME REACTOR; ESCHERICHIA COLI INFECTION; GENETIC ENGINEERING; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; MEMBRANE STRUCTURE; NONHUMAN; PRIORITY JOURNAL; BACTERIUM; GENE TRANSFER; GENETIC PROCEDURES; GENETICS; GRAM NEGATIVE BACTERIUM; HORIZONTAL GENE TRANSFER; IMMUNE SYSTEM; METABOLISM; NEOPLASM; REVIEW; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALIA; BACTERIA (MICROORGANISMS); NEGIBACTERIA;

BACTERIA; BACTERIAL VACCINES; DRUG CARRIERS; GENE TRANSFER TECHNIQUES; GENE TRANSFER, HORIZONTAL; GENETIC TECHNIQUES; GRAM-NEGATIVE BACTERIA; HUMANS; IMMUNE SYSTEM; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; NEOPLASMS; PROBIOTICS; VACCINES, DNA;

EID: 77955474710     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-1132-2_12     Document Type: Article

References (40)

1. Witte A, Wanner G, Bläsi U et al. Endogenous transmembrane tunnel formation mediated by phi X174 lysis protein E.J Bacteriol 1990; 172(7) :4109-14. (Pubitemid 20213400)
2. Eko Fa, Szostak MP, Wanner G et al. Production of Vibrio cholerae ghosts (VCG) by expression of a cloned phage lysis gene: potential for vaccine development. Vaccine 1994; 12(13) :1231-7 . (Pubitemid 24293246)
3. Jechlinger W; Szostak MP, Witte A et al. Altered temperature induction sensitivity of the lambda pRjc1857 system for controlled gene E expression in Escherichia coli. FEMS Microbiol Lett 1999; 173(2) :347-52. (Pubitemid 29146137)
4. Jechlinger W, Szostak MP, Lubitz w: Cold-sensitive E-lysis systems. Gene 1998: 218(1 -2):1-7. (Pubitemid 28434933)
5. Hardinger W; Szostak MP, Jechlinger W et al. Online monitoring of Escherichia coli ghost production. Appl Environ Microbiol 2003 ; 69(1) :468-74. (Pubitemid 36077509)
6. Haidinger W; Mayr VB, Szostak MP, et al. Escherichia coli ghost production by expression of lysis gene E and Staphylococcal nuclease. Appl Environ Microbiol 2003; 69(10):6106-13. (Pubitemid 37280335)
7. Riedmann EM et al. Bacterial ghosts as adjuvant particles . Expert Rev Vaccines 2007 ; 6(2) :241-53. (Pubitemid 46607459)
8. Hensel A, van Leengoed LA, Szostak M et al. Induction of protective immunity by aerosol or oral application of candidate vaccines in a dose-controlled pig aerosol infection model. J Biotechnol 1996: 44( 1-3):171-81. (Pubitemid 26056575)
9. Eko FO, Schukovskaya T, Lotzmanova EY et al. Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits . Vaccine 2003 ; 21(25-26):3663-74. (Pubitemid 37338191)
10. Mayr VB, Haller C, Haidinger W et al. Bacterial ghosts as an oral vaccine: a single dose of Escherichia coli 0157:H 7 bacterial ghosts protects mice against lethal challenge. Infect Immun 2005 ; 73(8):4810-7. (Pubitemid 41105637)
11. Mayr VB, Haller C, Haidinger W et al. Mucosal single dose immunization of mice with Escherichia coli 0157:H7 bacterial ghost s protects against lethal challenge.J Imrnunol, submitted 2007.
12. Witte A, Blasi V, Halfmann G et al. Phi Xl74 protein E-mediated lysis of Escherichia coli. Biochimie 1990; 72(2-3):191-200.
13. Witte A, Lubitz w: Biochemical characterization of phi XI74-protein-E-mediated lysis of Escherichia coli. Eur J Biochem 1989; 180(2) :393-8. (Pubitemid 19088830)
14. Witte A, Brand E, Mayrhofer P et al. Mutations in cell division proteins FtsZ and FtsA inhibit phiX174 protein-Evmediated lysis of Escherichia coli. Arch Microbiol 1998; 170(4) :259-68 . (Pubitemid 28430383)
15. Witte A, Schrot G, Schon P et al. Proline 21, a residue within the alpha-helical domain of phiX174 lysis protein E, is required for its function in Escherichia coli. Mol Microbiol 1997; 26(2) :337-46 (Pubitemid 27483682)
16. Witte A, Lubitz W; Bakker EP. Proton-motive-force-dependent step in the pathway to lysis of Escherichia coli induced by bacteriophage phi X174 geneE product. J Bacteriol 1987; 169(4):1750-2. (Pubitemid 17063512)
17. Halfnann G. Differentsensitivity of autolytic deficient Escherichia coli mutantsto the modeof induction. FEMS Microbiology Letters 1984; 24:205-208.
18. Lubitz W; Halfnann G, Plapp R. Lysis of Escherichia coli after infectionwith phiX174 depends on the regulation of the cellular autolytic system. J Gen Microbiol 1984; 130 ( Pt 5):1079-87. (Pubitemid 14114826)
19. Mayr UB, Walcher P, Azimpour C et al. Bacterial ghosts as antigen delivery vehicles. Adv Drug Deliv Rev 2005; 57(9):1381-91. (Pubitemid 40791117)
20. Eko FO, Mayr UB, Attridge SR et al. Characterization and immunogenicity of Vibrio cholerae ghosts expressing toxin-coregulated pili. J Biotechnol 2000; 83(1-2):115-23.
21. Kuen B, Lubitz W Analysis of S-Iyer proteins and genes in Crystalline Bacterial Cell Surface Proteins 1996; 77-102.
22. Szosta M, Auer T, Lubitz W Immuneresponse against recombinant bacterial ghosts, in Vaccines Cold Spring Harbor Laboratory Press 1993; 93:419-425.
23. Kuen B, SleytrUB, Lubitz W Sequence analysis of the sbsAgene encodingthe 130-kDa surface-layer protein of Bacillus srearothermophilus strain PV72. Gene 1994; 145(1):115-20. (Pubitemid 24224973)
24. Khan AS, Mujer Cv. Alefantis TG et al. Proteomics and Biolnformatics strategies to design countermeasures against infectious threat agents. J Chern lnf Model 2006; 46(1):111-5. (Pubitemid 43282105)
25. Eko FO, He Q, Brown T et al. A novel recombinant multisubunit vaccine against Chlamydia. J Immunol 2004; 173(5):3375-82. (Pubitemid 39142047)
26. Lubitz P et al. Bacterial ghosts as a delivery system for zona pellucida-2 fertility control vaccines for brushtail possums (trichosurus vulpecula), Vaccine, submitted 2007.
27. Paukner S et al.DNA-loaded bacterial ghosts efficiently mediate reporter gene transfer and expression in macrophages. Mol Ther 2005; 11(2):215-23.
28. Kudela P, Paukner S, Mayr UB et al. Bacterial ghosts as novel efficient targeting vehicles for DNA delivery to the human monocyte-derived dendritic cells. J Immunother; 2005; 28(2):136-43. (Pubitemid 40328200)
29. Ebensen T, Paukner S, Link C et al. Bacterial ghostsare an efficient delivery system for DNA vaccines. J Immunol 2004; 172(11):6858-65. (Pubitemid 38669124)
30. Mayrhofer P,Tabrizi CA, Walcher P et al. Immobilization of plasmid DNA in bacterial ghosts. J Control Release 2005; 102(3):725-35. (Pubitemid 40170214)
31. Jechlinger W; Azimpour Tabrizi C, Lubitz W et al. Minicircle DNA immobilized in bacterial ghosts. in vivo production of safe nonviral DNA delivery vehicles. J Mol Microbiol Biotechnol 2004; 8(4):222-31. (Pubitemid 41368967)
32. Brady MS, Lee F, Petrie H et al. CD4(-) T-cells kill HLA-class-II- antigen-positive melanoma cells presentingpeptide in vitro. Cancer Immunol Immunother 2000; 48(11):621-6. (Pubitemid 30064664)
33. Curiel-Lewandrowski C, DemierreME Advances in specific immuno therapy of malignant melanoma. J Am Acad Dermatol 2000; 43(2 Pt 1):167-85; quiz 186-8. (Pubitemid 30625992)
34. Kudela P et al.. Effectivegene transfer to meanoma cells using bacterial ghosts. Cancer Letters 2007; in press.
35. Paukner S, Kohl G, Lubitz W Bacterial ghostsas novel advanced drugdelivery systems: antiproliferative activity of loaded doxorubicin in human Caco2 cells. J Control Release 2004; 94(1):63-74. (Pubitemid 37542378)
36. Huter V. Szostak MP,Gampfer J et al. Bacterial ghostsas drug carrier and targetingvehicles. J Control Release 1999; 61(1-2):51-63. (Pubitemid 29406079)
37. Hatfaludi T, Liska M, Zeilinger D et al. Bacterial ghost technology for pesticide delivery. J Agric Food Chern 2004; 52(18):5627-34.
38. Maratea D, Young K, Young R. Deletion and fusion analysis of the phagephi X174 lysis geneE. Gene 1985; 40(1):39-46. (Pubitemid 16132024)
39. Bahl H, Scholz H, Bayan N et al. Molecular biology of S-Iayers. FEMS Microbiol Rev 1997; 20(1-2):47-98.
40. Paukner S, Kohl G, Jalava K et al. Sealed bacterial ghosts-novel targetingvehicles for advanced drug delivery of water-soluble substances. J Drug Target 2003; 11(3):151-61. (Pubitemid 37236328)